In March, the FDA cleared Dexcom’s Stelo, making it the first glucose biosensor that doesn’t require a prescription. The small, wearable device, worn on the back of the upper arm, is designed for people with Type 2 diabetes or pre-diabetes who are not using insulin. The corresponding app offers readouts, showing when users’ glucose levels spike and ebb throughout the day. “When someone sees their own personal data, that’s empowering, because they can do something about it,” says COO Jake Leach. Indeed, the app helps teach users how to minimize glucose spikes, by, say, eating fiber first during meals or taking a walk straight after eating.
Buy Now: Glucose Biosensor on Stelo
More Must-Reads from TIME
- Why Trump’s Message Worked on Latino Men
- What Trump’s Win Could Mean for Housing
- The 100 Must-Read Books of 2024
- Sleep Doctors Share the 1 Tip That’s Changed Their Lives
- Column: Let’s Bring Back Romance
- What It’s Like to Have Long COVID As a Kid
- FX’s Say Nothing Is the Must-Watch Political Thriller of 2024
- Merle Bombardieri Is Helping People Make the Baby Decision
Contact us at letters@time.com